200 related articles for article (PubMed ID: 34229724)
21. Altered frequencies of memory B cells in new-onset systemic lupus erythematosus patients.
Zhu L; Yin Z; Ju B; Zhang J; Wang Y; Lv X; Hao Z; He L
Clin Rheumatol; 2018 Jan; 37(1):205-212. PubMed ID: 29067587
[TBL] [Abstract][Full Text] [Related]
22. Altered B cell phenotype and CD27+ memory B cells are associated with clinical features and environmental exposure in Colombian systemic lupus erythematosus patients.
Hurtado C; Rojas-Gualdrón DF; Urrego R; Cashman K; Vásquez-Trespalacios EM; Díaz-Coronado JC; Rojas M; Jenks S; Vásquez G; Sanz I
Front Med (Lausanne); 2022; 9():950452. PubMed ID: 36148466
[TBL] [Abstract][Full Text] [Related]
23. Peripheral CD24hi CD27+ CD19+ B cells subset as a potential biomarker in naïve systemic lupus erythematosus.
Jin L; Weiqian C; Lihuan Y
Int J Rheum Dis; 2013 Dec; 16(6):698-708. PubMed ID: 24286662
[TBL] [Abstract][Full Text] [Related]
24. [Increased serum C-C chemokine ligand 19 levels correlated with B cell abnormalities in systemic lupus erythematosus].
Liu HJ; Shi LJ; Hu FL; Yao HH; Li ZG; Jia Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):829-834. PubMed ID: 29045964
[TBL] [Abstract][Full Text] [Related]
25. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.
Bijl M; Horst G; Limburg PC; Kallenberg CG
Ann Rheum Dis; 2001 May; 60(5):523-6. PubMed ID: 11302879
[TBL] [Abstract][Full Text] [Related]
26. Safety and pharmacodynamics of venetoclax (ABT-199) in a randomized single and multiple ascending dose study in women with systemic lupus erythematosus.
Lu P; Fleischmann R; Curtis C; Ignatenko S; Clarke SH; Desai M; Wong SL; Grebe KM; Black K; Zeng J; Stolzenbach J; Medema JK
Lupus; 2018 Feb; 27(2):290-302. PubMed ID: 28691866
[TBL] [Abstract][Full Text] [Related]
27. In vitro induction of IgG anti-DNA antibody from high density B cells of systemic lupus erythematosus patients by an HLA DR-restricted T cell clone.
Murakami M; Kumagai S; Sugita M; Iwai K; Imura H
Clin Exp Immunol; 1992 Nov; 90(2):245-50. PubMed ID: 1424281
[TBL] [Abstract][Full Text] [Related]
28. Subset size, activation threshold and distribution of autoreactive MZ and FO B cells do not differ in a sex-specific manner in the NZB/W F1 murine lupus model: an experimental mouse study.
Enghard P; Grussie E; Rieder C; Burmester GR; Riemekasten G
Lupus; 2011 Oct; 20(12):1240-9. PubMed ID: 21844114
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
30. Expanded circulating peripheral helper T cells in systemic lupus erythematosus: association with disease activity and B cell differentiation.
Makiyama A; Chiba A; Noto D; Murayama G; Yamaji K; Tamura N; Miyake S
Rheumatology (Oxford); 2019 Oct; 58(10):1861-1869. PubMed ID: 30879065
[TBL] [Abstract][Full Text] [Related]
31. Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients.
Rodríguez-Bayona B; Ramos-Amaya A; Pérez-Venegas JJ; Rodríguez C; Brieva JA
Arthritis Res Ther; 2010; 12(3):R108. PubMed ID: 20525218
[TBL] [Abstract][Full Text] [Related]
32. Expansion of extrafollicular B and T cell subsets in childhood-onset systemic lupus erythematosus.
Baxter RM; Wang CS; Garcia-Perez JE; Kong DS; Coleman BM; Larchenko V; Schuyler RP; Jackson C; Ghosh T; Rudra P; Paul D; Claassen M; Rochford R; Cambier JC; Ghosh D; Cooper JC; Smith MJ; Hsieh EWY
Front Immunol; 2023; 14():1208282. PubMed ID: 37965329
[TBL] [Abstract][Full Text] [Related]
33. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
[TBL] [Abstract][Full Text] [Related]
34. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
35. The role and clinical significance of programmed cell death- ligand 1 expressed on CD19
Jia XY; Zhu QQ; Wang YY; Lu Y; Li ZJ; Li BQ; Tang J; Wang HT; Song CW; Xie CH; Chen LJ
Clin Immunol; 2019 Jan; 198():89-99. PubMed ID: 30502542
[TBL] [Abstract][Full Text] [Related]
36. Class switching and consecutive loss of dsDNA-reactive B1a B cells from the peritoneal cavity during murine lupus development.
Enghard P; Humrich JY; Chu VT; Grussie E; Hiepe F; Burmester GR; Radbruch A; Berek C; Riemekasten G
Eur J Immunol; 2010 Jun; 40(6):1809-18. PubMed ID: 20333624
[TBL] [Abstract][Full Text] [Related]
37. Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE).
Spronk PE; Horst G; Van Der Gun BT; Limburg PC; Kallenberg CG
Clin Exp Immunol; 1996 Jun; 104(3):446-53. PubMed ID: 9099929
[TBL] [Abstract][Full Text] [Related]
38. Fucosylation of anti-dsDNA IgG1 correlates with disease activity of treatment-naïve systemic lupus erythematosus patients.
Han J; Zhou Z; Zhang R; You Y; Guo Z; Huang J; Wang F; Sun Y; Liu H; Cheng X; Su Y; Shi H; Hu Q; Teng J; Yang C; Ren S; Ye J
EBioMedicine; 2022 Mar; 77():103883. PubMed ID: 35182998
[TBL] [Abstract][Full Text] [Related]
39. Precursor frequencies for DNA-specific B lymphocytes in patients with systemic lupus erythematosus (SLE).
Schwab J; Lukowsky A; Volk HD; Peter HH; Melchers I
Clin Exp Immunol; 1994 Jun; 96(3):450-7. PubMed ID: 8004815
[TBL] [Abstract][Full Text] [Related]
40. Suppression of autoreactive T and B lymphocytes by anti-annexin A1 antibody in a humanized NSG murine model of systemic lupus erythematosus.
Mihaylova N; Chipinski P; Bradyanova S; Velikova T; Ivanova-Todorova E; Chausheva S; Herbáth M; Kalinova D; Prechl J; Kyurkchiev D; Tchorbanov AI
Clin Exp Immunol; 2020 Mar; 199(3):278-293. PubMed ID: 31724735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
